7 Related NICE guidance


Under development

NICE is developing the following guidance (details available from the NICE website):

  • Ipilimumab in combination with dacarbazine for previously untreated unresectable stageĀ III or IV malignant melanoma (publication date to be confirmed).

  • Skin cancer: how the NHS and local authorities can help prevent skin cancer using public information, sun protection resources and by making changes to the environment (publication date to be confirmed).

  • National Institute for Health and Care Excellence (NICE)